David Feece, PA
Physician Assistant · Greenwood, SCNPI 1245600956
Payments from drug & device makers
Across 247 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$832
- Sumitomo Pharma America, Inc.$413
- Antares Pharma, Inc.$411
- Astellas Pharma US Inc$409
- AbbVie$403
- Coloplast$385
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,85293%
- Education$3497%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 29 | $832 |
| Sumitomo Pharma America, Inc. | 17 | $413 |
| Antares Pharma, Inc. | 23 | $411 |
| Astellas Pharma US Inc | 19 | $409 |
| AbbVie | 16 | $403 |
| Coloplast | 24 | $385 |
| Endo Pharmaceuticals Inc. | 23 | $353 |
| Endo USA, Inc. | 12 | $245 |
| Boston Scientific | 11 | $222 |
| Rochester Medical Corporation | 10 | $200 |
| C. R. Bard, Inc. & Subsidiaries | 4 | $150 |
| Medtronic | 5 | $131 |
| Urovant Sciences Inc | 7 | $125 |
| Ferring Pharmaceuticals Inc. | 4 | $82 |
| Teleflex LLC | 4 | $77 |
| Axonics, Inc. | 3 | $62 |
| Merck | 4 | $60 |
| 180 Medical, Inc. | 2 | $58 |
| Laborie Medical Technologies Corp. | 2 | $53 |
| Hollister Incorporated | 3 | $45 |
| Pfizer | 2 | $42 |
| Olympus America Inc. | 1 | $40 |
| Procept Biorobotics Corporation | 1 | $38 |
| Blue Earth Diagnostics | 2 | $38 |
| Urogen Pharma, Inc. | 2 | $37 |
| AstraZeneca | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Halozyme Inc | 2 | $27 |
| Clarus Therapeutics Inc. | 2 | $27 |
| Sagent Pharmaceuticals | 1 | $26 |
| Tolmar, Inc. | 1 | $24 |
| BD | 1 | $24 |
| Myovant Sciences Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Davol Inc. | 1 | $17 |
| ABC Home Medical Supply, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Ambu Inc. | 2 | $15 |
How this compares
$5,201 in reported general payments places this provider in the 90th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiaflexCollagenase Clostridium Hist. | 17 | $215,998 |
| MyrbetriqMirabegron | 145 | $102,694 |
| GemtesaVibegron | 111 | $90,418 |
| ElmironPentosan Polysulfate Sodium | 15 | $13,457 |
| Tamsulosin Hcl | 703 | $10,127 |
| Estradiol | 85 | $6,294 |
| Finasteride | 280 | $4,132 |
| Solifenacin Succinate | 52 | $4,055 |
| Testosterone | 15 | $2,962 |
| Methenamine Hippurate | 22 | $2,143 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 79 | $1,874 |
| Trimethoprim | 26 | $1,866 |
| Testosterone Cypionate | 56 | $1,776 |
| Bethanechol Chloride | 40 | $1,764 |
| Desmopressin Acetate | 31 | $1,692 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Endo Pharmaceuticals Inc.Xiaflex | $353 | $215,99817 claims |
| Astellas Pharma US IncMyrbetriq | $409 | $102,694145 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $413 | $90,418111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Greenwood
- Wesley PattersonGreenwood$19K
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.